158 related articles for article (PubMed ID: 30041611)
1. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
Ma J; Fu Y; Tu YY; Liu Y; Tan YR; Ju WT; Pickering CR; Myers JN; Zhang ZY; Zhong LP
BMC Cancer; 2018 Jul; 18(1):758. PubMed ID: 30041611
[TBL] [Abstract][Full Text] [Related]
2. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
3. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
[TBL] [Abstract][Full Text] [Related]
4. Absence of the frequently reported PIK3CA, CASP8, and NOTCH1 mutations in South Indian oral cancers.
Arunkumar G; Murugan AK; Nagarajan M; Ajay C; Rajaraman R; Munirajan AK
Oral Dis; 2017 Jul; 23(5):669-673. PubMed ID: 28181739
[TBL] [Abstract][Full Text] [Related]
5. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
[TBL] [Abstract][Full Text] [Related]
6. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
[TBL] [Abstract][Full Text] [Related]
7. Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.
Song X; Xia R; Li J; Long Z; Ren H; Chen W; Mao L
Clin Cancer Res; 2014 Feb; 20(3):701-10. PubMed ID: 24277457
[TBL] [Abstract][Full Text] [Related]
8. Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension.
Wang HM; Liao CT; Yen TC; Chen SJ; Lee LY; Hsieh CH; Lin CY; Ng SH
Oncotarget; 2016 Sep; 7(39):63082-63092. PubMed ID: 27590518
[TBL] [Abstract][Full Text] [Related]
9. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma.
Ma J; Tang X; Sun WW; Liu Y; Tan YR; Ma HL; Zhu DW; Wang M; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP
Oncotarget; 2016 Jan; 7(2):2113-22. PubMed ID: 26544895
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
[TBL] [Abstract][Full Text] [Related]
11. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma.
Oikawa Y; Morita KI; Kayamori K; Tanimoto K; Sakamoto K; Katoh H; Ishikawa S; Inazawa J; Harada H
Cancer Sci; 2017 Feb; 108(2):256-266. PubMed ID: 27889930
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation analysis by bisulfite next-generation sequencing for early detection of oral squamous cell carcinoma and high-grade squamous intraepithelial lesion from oral brushing.
Morandi L; Gissi D; Tarsitano A; Asioli S; Monti V; Del Corso G; Marchetti C; Montebugnoli L; Foschini MP
J Craniomaxillofac Surg; 2015 Oct; 43(8):1494-500. PubMed ID: 26302938
[TBL] [Abstract][Full Text] [Related]
13. FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.
Tanuma J; Izumo T; Hirano M; Oyazato Y; Hori F; Umemura E; Shisa H; Hiai H; Kitano M
Oncol Rep; 2010 Mar; 23(3):739-44. PubMed ID: 20127014
[TBL] [Abstract][Full Text] [Related]
14. Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
Sutton LA; Ljungström V; Mansouri L; Young E; Cortese D; Navrkalova V; Malcikova J; Muggen AF; Trbusek M; Panagiotidis P; Davi F; Belessi C; Langerak AW; Ghia P; Pospisilova S; Stamatopoulos K; Rosenquist R
Haematologica; 2015 Mar; 100(3):370-6. PubMed ID: 25480502
[TBL] [Abstract][Full Text] [Related]
15. Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma.
Padhi SS; Roy S; Kar M; Saha A; Roy S; Adhya A; Baisakh M; Banerjee B
Oral Oncol; 2017 Oct; 73():27-35. PubMed ID: 28939073
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
[TBL] [Abstract][Full Text] [Related]
17. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
[TBL] [Abstract][Full Text] [Related]
18. [Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma].
Xie S; Cai ZG; Shan XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):697-701. PubMed ID: 37534654
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.
Er TK; Wang YY; Chen CC; Herreros-Villanueva M; Liu TC; Yuan SS
Oral Dis; 2015 Oct; 21(7):872-8. PubMed ID: 26173098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]